“Omalizumab As an Adjuvant Therapy for Treating Severe Atopic Dermatitis in Children. A Series of Cases”. Revista Alergia México, vol. 66, no. 3, June 2019, pp. 282-91, https://doi.org/10.29262/ram.v66i3.401.